Canopy Growth completes recapitalization, reports medical cannabis revenue growth

The Motley Fool··CADE·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Canopy Growth has completed a major recapitalization that significantly reduced its debt burden, ending fiscal 2026 with about $131.3 million in net cash. The company reported 27% fourth-quarter revenue growth in Canadian medical cannabis and 68% growth in international medical cannabis, driven by markets such as Germany. Management has streamlined operations, exited non-core businesses like BioSteel, and completed the acquisition of MTL Cannabis. Despite these improvements, Canopy Growth remains unprofitable and faces intense competition in the Canadian recreational market.

Impact on assets 2

Health Care▲ · 1 stocks
Canopy Growth Corp
CGC
▲ PositiveCapitalrelevance

Completed recapitalization reducing debt and ending with net cash, plus revenue growth in medical cannabis.

Artificial Intelligence▲ · 1 stocks

Off-coverage companies 1

BioSteel Sports Nutrition Inc.Private▼ Negative
Capitalrelevance

Exited non-core business BioSteel, indicating divestiture.

© 2026 MarketIVNews